Astrazeneca Pharma India rises on LOI with Reliance's Strand Life Sciences
** Shares of Astrazeneca Pharma India ASTR.NS rise 2.4% to 6,182 rupees
** Pharmaceutical co signs letter of intent (LOI) with Strand Life Sciences, a subsidiary of Reliance Industries RELI.NS
** ASTR signs LOI to explore opportunities to collaborate in healthcare in India
** Stock down 32.44% YTD